Daral Jackwood, PhD
Ohio State University
Dr. Daral J. Jackwood is a Professor Emeritus in the College of Veterinary Medicine, Food Animal Health Research Program at The Ohio State University, Ohio Agricultural Research and Development Center. He earned his B.S. from the University of Delaware and his M.S. and Ph.D. at The Ohio State University.
Dr. D. Jackwood is a Molecular Virologist and his primary area of research was immunosuppressive viruses particularly the Birnavirus known as infectious bursal disease virus (IBDV). His studies have examined the evolution of IBDV strains around the world. This work was focused on the molecular characteristics of IBDV strains; including examining the molecular basis for immunogenic, antigenic and pathogenic properties of these viruses. Serology and molecular techniques were used to differentiate the various antigenic and pathogenic types of IBDV. Dr. Jackwood has also examined the potential of multivalent vaccines for the control of infectious bursal disease. He has over 95 peer reviewed articles published in scientific journals and more than 200 abstracts and proceedings published from presentations given at scientific conferences. His work is internationally recognized and he has given invited talks on IBDV in numerous countries around the world. In 2013, he started a company to commercialize vaccines and diagnostic reagents based on virus-like-particle technology developed from his research at The Ohio State University. He continues to work at his company Larad, Inc.
Dr. Daral J. Jackwood is a Professor Emeritus in the College of Veterinary Medicine, Food Animal Health Research Program at The Ohio State University, Ohio Agricultural Research and Development Center. He earned his B.S. from the University of Delaware and his M.S. and Ph.D. at The Ohio State University.
Dr. D. Jackwood is a Molecular Virologist and his primary area of research was immunosuppressive viruses particularly the Birnavirus known as infectious bursal disease virus (IBDV). His studies have examined the evolution of IBDV strains around the world. This work was focused on the molecular characteristics of IBDV strains; including examining the molecular basis for immunogenic, antigenic and pathogenic properties of these viruses. Serology and molecular techniques were used to differentiate the various antigenic and pathogenic types of IBDV. Dr. Jackwood has also examined the potential of multivalent vaccines for the control of infectious bursal disease. He has over 95 peer reviewed articles published in scientific journals and more than 200 abstracts and proceedings published from presentations given at scientific conferences. His work is internationally recognized and he has given invited talks on IBDV in numerous countries around the world. In 2013, he started a company to commercialize vaccines and diagnostic reagents based on virus-like-particle technology developed from his research at The Ohio State University. He continues to work at his company Larad, Inc.